Cytoreductive Surgery (CRS) is a surgical procedure used to remove cancer cells from the body. It is typically used in combination with other treatments such as chemotherapy and radiation therapy. The goal of CRS is to reduce the number of cancer cells in the body and thereby improve the chances of survival. CRS involves removing the tumor, along with the surrounding tumor tissue and lymph nodes. This is done by making an incision in the skin and cutting away the cancerous tissue. In some cases, the entire organ may need to be removed. This is known as an organ resection. CRS may be used to treat cancer in many different organs, such as the ovaries, lungs, liver, pancreas, and colon. It is most often used for ovarian cancer, but may be used for other types of cancer as well. CRS is a complex procedure and is often used in combination with other treatments. The procedure can be lengthy and the recovery time can be long. The risks associated with CRS include infection, bleeding, and damage to surrounding organs.
Title : Male factors in recurrent pregnancy loss
Nicoletta Di Simone, Humanitas University Milan, Italy
Title : Application of thread technology in aesthetic and functional gynecology
Marlen Sulamanidze, Plastic Surgeon, Georgia
Title : Pulmonary embolism in pregnancy
Irene Eirini Orfanoudaki, University Hospital, Heraklion, Greece
Title : Understanding pelvic organ prolapse
Woojin Chong, NYU Langone Medical Center, United States
Title : Vaginal colonization by uropathogenic microorganisms: A key contributor to reproductive failure in mice
Vijay Prabha, Panjab University, India
Title : Role of artificial intelligence in the diagnosis and management of endometriosis. The prospect of the future
Mohamed M Hosni, London North West University Healthcare NHS Trust, United Kingdom